রুমানিয়া -
রোমানীয় -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
rivaroxaban teva 15 mg
teva pharma b.v. - tarile de jos - rivaroxabanum - compr. film. - 15mg - antitrombotice inhibitori directi ai factorului xa
রুমানিয়া -
রোমানীয় -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
rivaroxaban teva 2,5 mg
teva pharma b.v. - tarile de jos - rivaroxabanum - compr. film. - 2,5mg - antitrombotice inhibitori directi ai factorului xa
রুমানিয়া -
রোমানীয় -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
rivaroxaban teva 20 mg
teva pharma b.v. - tarile de jos - rivaroxabanum - compr. film. - 20mg - antitrombotice inhibitori directi ai factorului xa
রুমানিয়া -
রোমানীয় -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
rombidux 20 mg
merck healthcare kgaa - germania - rivaroxabanum - compr. film. - 20mg - antitrombotice inhibitori directi ai factorului xa
রুমানিয়া -
রোমানীয় -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
rombidux 15 mg
merck healthcare kgaa - germania - rivaroxabanum - compr. film. - 15mg - antitrombotice inhibitori directi ai factorului xa
ইউরোপীয় ইউনিয়ন -
রোমানীয় -
EMA (European Medicines Agency)
xarelto
bayer ag - rivaroxaban - arthroplasty, replacement; venous thromboembolism - agenți antitrombotici - xarelto, administrat concomitent cu acidul acetilsalicilic (aas) singur sau cu asa plus clopidogrel sau ticlopidina, este indicat pentru prevenirea evenimentelor aterotrombotice la pacienții adulți după un sindrom coronarian acut (sca) cu valori crescute biomarkerii cardiaci. xarelto, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. prevenirea tromboembolismului venos (vte) la pacienții adulți supuși unei intervenții chirurgicale de înlocuire a șoldului sau a genunchiului. tratamentul trombozei venoase profunde (tvp) și embolie pulmonară (ep), și prevenirea tvp și ep recurente la adulți. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
রুমানিয়া -
রোমানীয় -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
runaplax 10 mg
salutas pharma gmbh - germania - rivaroxabanum - compr. film. - 10mg - antitrombotice inhibitori directi ai factorului xa
রুমানিয়া -
রোমানীয় -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
rombidux 10 mg
merck healthcare kgaa - germania - rivaroxabanum - compr. film. - 10mg - antitrombotice inhibitori directi ai factorului xa
রুমানিয়া -
রোমানীয় -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
closderive 15 mg
swyssi ag - germania - rivaroxabanum - compr. film. - 15mg - antitrombotice inhibitori directi ai factorului xa
রুমানিয়া -
রোমানীয় -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
closderive 20 mg
swyssi ag - germania - rivaroxabanum - compr. film. - 20mg - antitrombotice inhibitori directi ai factorului xa